Rayburn W F
Department of Obstetrics and Gynecology, University of Oklahoma College of Medicine, Oklahoma City 73190, USA.
J Reprod Med. 1997 Jan;42(1):1-24.
This report summarizes experience with representative drugs used to treat patients with medical disorders existing before pregnancy. Preconception counseling is ideal for determining whether drug therapy needs to be continued or altered. Focusing on the underlying disorder or morbid co-conditions, not the drug alone, may explain any additional hazards to the fetus. Avoiding multiple medications and selecting that which is presumably safest are encouraged. The best means of monitoring the safety and efficacy of therapy should be determined. Few drugs and their metabolites are linked to either specific birth defects or life-threatening problems, but their effects on the developing fetal circulation and central nervous systems are difficult to predict. Despite attempts to minimize fetal exposure, an increase in either the daily dose or duration of drug therapy may be necessary for optimal results. Although no drug is absolutely safe, the healthiest mother is most likely to deliver the healthiest infant.
本报告总结了用于治疗妊娠前存在的内科疾病患者的代表性药物的使用经验。孕前咨询是确定是否需要继续或改变药物治疗的理想方式。关注潜在疾病或合并症,而不仅仅是药物本身,可能会解释对胎儿的任何额外风险。鼓励避免使用多种药物,并选择可能最安全的药物。应确定监测治疗安全性和有效性的最佳方法。很少有药物及其代谢产物与特定的出生缺陷或危及生命的问题相关,但它们对发育中的胎儿循环和中枢神经系统的影响很难预测。尽管试图尽量减少胎儿接触药物,但为了达到最佳效果,可能需要增加药物治疗的每日剂量或持续时间。虽然没有药物是绝对安全的,但最健康的母亲最有可能生下最健康的婴儿。